THE AFFILIATED HOSPITAL OF QINGDAO UNIVERSITY
🇨🇳China
Effect of Intraperitoneal Drain Placement on Postoperative Outcomes Following Laparoscopic Appendectomy in Adult Patients With Perforated Appendicitis
Active, not recruiting
- Conditions
- Perforated Appendicitis
- First Posted Date
- 2025-04-15
- Last Posted Date
- 2025-04-15
- Lead Sponsor
- The Affiliated Hospital of Qingdao University
- Target Recruit Count
- 500
- Registration Number
- NCT06927765
- Locations
- 🇨🇳
The Affiliated Hospital of Qingdao University, Qingdao', Shandong, China
Clinical Study of 18F-Labeled FAPI-04 in PET Imaging of Breast Cancer
Recruiting
- Conditions
- Breast Cancer
- First Posted Date
- 2025-04-08
- Last Posted Date
- 2025-04-29
- Lead Sponsor
- The Affiliated Hospital of Qingdao University
- Target Recruit Count
- 30
- Registration Number
- NCT06916338
- Locations
- 🇨🇳
The Affiliated Hospital of Qingdao University, Qingdao, Shandong, China
Multicenter Study of 18F-Labeled NY104 for PET/CT Imaging in Renal Cell Carcinoma
Recruiting
- Conditions
- Renal Cell Carcinoma (RCC)Clear Cell Renal Cell Carcinoma (ccRCC)
- First Posted Date
- 2025-04-08
- Last Posted Date
- 2025-04-29
- Lead Sponsor
- The Affiliated Hospital of Qingdao University
- Target Recruit Count
- 40
- Registration Number
- NCT06916624
- Locations
- 🇨🇳
The Affiliated Hospital of Qingdao University, Qingdao, Shandong, China
Clinical Study on the Application of 18F-HER2 Affibody PET Imaging in HER2-Expressing Breast Cancer
Recruiting
- Conditions
- Breast CancerBreast Cancer, HER2-Expression
- First Posted Date
- 2025-04-08
- Last Posted Date
- 2025-04-30
- Lead Sponsor
- The Affiliated Hospital of Qingdao University
- Target Recruit Count
- 40
- Registration Number
- NCT06916637
- Locations
- 🇨🇳
Affiliated Hospital of Qingdao University, Qingdao, Shandong, China
A Single-center, Open, Randomized, Single-dose, Cross-over Bioequivalence Study to Evaluate the Effects of the Test Formulation Abalparatide Injection and the Reference Formulation Abalparatide Injection (Tymlos®) in Healthy Adult Subjects
Phase 1
Not yet recruiting
- Conditions
- Osteoporosis
- Interventions
- Drug: Test (T)Drug: Reference (R)
- First Posted Date
- 2024-12-31
- Last Posted Date
- 2024-12-31
- Lead Sponsor
- The Affiliated Hospital of Qingdao University
- Target Recruit Count
- 32
- Registration Number
- NCT06753864
- Locations
- 🇨🇳
The Affiliated Hospital of Qingdao University, Qingdao, Shandong, China
Construction and Effectiveness Evaluation of Painless Digestive Endoscopy Mode Led by Anesthesia Nurses Under the Guidance of Anesthesiologists
- Conditions
- Pain ManagementEndoscopy, Gastrointestinal
- First Posted Date
- 2024-12-02
- Last Posted Date
- 2025-02-06
- Lead Sponsor
- The Affiliated Hospital of Qingdao University
- Target Recruit Count
- 10000
- Registration Number
- NCT06712264
- Locations
- 🇨🇳
the Affiliated Hospital of Qingdao University, Qingdao, Shandong, China
An Observational Study on Respiratory Complications After Gastrointestinal Endoscopy Assisted With Anesthesia
Completed
- Conditions
- Pneumonia, Aspiration
- First Posted Date
- 2024-11-26
- Last Posted Date
- 2025-04-09
- Lead Sponsor
- The Affiliated Hospital of Qingdao University
- Target Recruit Count
- 6739
- Registration Number
- NCT06705894
- Locations
- 🇨🇳
The Affiliated Hospital of Qingdao University, Qingdao, Shangdong, China
Study on Human Bioequivalence of Triprerelin Acetate for Injection
Phase 1
Recruiting
- Conditions
- Prostate Cancer (CRPC)
- Interventions
- Drug: Triprorelin for injection
- First Posted Date
- 2024-11-11
- Last Posted Date
- 2024-11-11
- Lead Sponsor
- The Affiliated Hospital of Qingdao University
- Target Recruit Count
- 120
- Registration Number
- NCT06683066
- Locations
- 🇨🇳
The Affiliated Hospital of Qingdao University, Qingdao, Shandong, China
Comparison of the Clinical Efficacy and Safety of Endoscopic Superior Rectal Mucosal Ligation and Hemorrhoids Ligation
Not Applicable
Not yet recruiting
- Conditions
- Hemorrhoids
- First Posted Date
- 2024-10-21
- Last Posted Date
- 2024-10-21
- Lead Sponsor
- The Affiliated Hospital of Qingdao University
- Target Recruit Count
- 96
- Registration Number
- NCT06649786
Neoadjuvant Chemotherapy and PD-1 Inhibitor for Locally Advanced Rectal Cancer
Phase 2
Not yet recruiting
- Conditions
- Rectal Cancer Patients
- Interventions
- Drug: Receive the experimental combination of drugs (chemoradiation (Oxaliplatin and Capecitabine) + PD-1 inhibitor (Tislelizumab) for 3 cycles
- First Posted Date
- 2024-10-18
- Last Posted Date
- 2024-10-18
- Lead Sponsor
- The Affiliated Hospital of Qingdao University
- Target Recruit Count
- 35
- Registration Number
- NCT06647680
© Copyright 2025. All Rights Reserved by MedPath